Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation

Mesenchymal stem cells (MSCs) have natural immunoregulatory functions that have been explored for medicinal use as a cell therapy with limited success. A phase Ib study was conducted to evaluate the safety and immunoregulatory mechanism of action of MSCs using a novel ex vivo product (SBI‐101) to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Swaminathan, Madhav, Kopyt, Nelson, Atta, Mohamed G., Radhakrishnan, Jai, Umanath, Kausik, Nguyen, Sunny, O'Rourke, Brian, Allen, Ashley, Vaninov, Natalie, Tilles, Arno, LaPointe, Elizabeth, Blair, Andrew, Gemmiti, Chris, Miller, Brian, Parekkadan, Biju, Barcia, Rita N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641088/
https://www.ncbi.nlm.nih.gov/pubmed/34581517
http://dx.doi.org/10.1002/sctm.21-0043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641088/
https://www.ncbi.nlm.nih.gov/pubmed/34581517
http://dx.doi.org/10.1002/sctm.21-0043

Ejemplares similares